An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for MODERNA Inc
| Ticker | MRNA |
| FIGI | BBG003PHHZT1 |
| CUSIP | 60770K107 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 884 / 12.8% |
| Percentage held by institutional investors | 67.3% |
About
Moderna, Inc. ( mə-DUR-nə) is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".The company's only commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have entered clinical trials. Wikipedia